Clinical Trial Update: Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the safety of Osocimab at low and high doses in adults with end-stage renal disease on hemodialysis; results posted after comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hemodialysis-related Conditions
• Prevention of Thromboembolic Events

Drugs mentioned

• Osocimab (Osocimab)

Snippet

Sponsor: Bayer | Conditions: End-stage Renal Disease, Prevention of Thromboembolic Events | Phase 2 | Status: COMPLETED | Results posted: 2023-07-21